Podcasts Innovative solutions to the drug pricing crisis: the pharmap... In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
